Cargando…
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310099/ https://www.ncbi.nlm.nih.gov/pubmed/32040189 http://dx.doi.org/10.1093/rheumatology/keaa047 |
| _version_ | 1783549305094668288 |
|---|---|
| author | Kersten, Brigit E den Broeder, Nathan van den Hoogen, Frank H J Knaapen-Hans, Hanneke A K van den Ende, Cornelia H M Vonk, Madelon C |
| author_facet | Kersten, Brigit E den Broeder, Nathan van den Hoogen, Frank H J Knaapen-Hans, Hanneke A K van den Ende, Cornelia H M Vonk, Madelon C |
| author_sort | Kersten, Brigit E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7310099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73100992020-06-29 Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis Kersten, Brigit E den Broeder, Nathan van den Hoogen, Frank H J Knaapen-Hans, Hanneke A K van den Ende, Cornelia H M Vonk, Madelon C Rheumatology (Oxford) Corrigenda Oxford University Press 2020-07 2020-02-10 /pmc/articles/PMC7310099/ /pubmed/32040189 http://dx.doi.org/10.1093/rheumatology/keaa047 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigenda Kersten, Brigit E den Broeder, Nathan van den Hoogen, Frank H J Knaapen-Hans, Hanneke A K van den Ende, Cornelia H M Vonk, Madelon C Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title | Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title_full | Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title_fullStr | Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title_full_unstemmed | Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title_short | Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| title_sort | treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310099/ https://www.ncbi.nlm.nih.gov/pubmed/32040189 http://dx.doi.org/10.1093/rheumatology/keaa047 |
| work_keys_str_mv | AT kerstenbrigite treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis AT denbroedernathan treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis AT vandenhoogenfrankhj treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis AT knaapenhanshannekeak treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis AT vandenendecorneliahm treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis AT vonkmadelonc treatmentwithcyclophosphamideivpulsetherapyisanoptionforeffectivetreatmentofskinfibrosisinpatientswithearlysystemicsclerosis |